...
search icon
cocp-img

Cocrystal Pharma Inc, Common Stock

COCP

NAQ

$1.8541

-$0.01

(-0.54%)

1D
Industry: Pharmaceuticals Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$18.86M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
15.42K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.45
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.32 L
$3.26 H
$1.8541

About Cocrystal Pharma Inc, Common Stock

Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, norovirus, and respiratory virus infections. The company develops CC-31244, a HCV non-nucleoside polymerase inhibitor that has completed Phase II a clinical trial to treat HCV infection; and CC-42344, a PB2 inhibitor that has completed Phase I clinical trial for treating influenza infection. It is also involved in identifying and developing non-nucleoside polymerase inhibitors for norovirus infections. Cocrystal Pharma, Inc. has a license and research collaboration agreement with Merck Sharp & Dohme Corp. to discover and develop proprietary influenza A/B antiviral agents; and a license agreement with Kansas State University Research Foundation to develop antiviral compounds for the treatment of norovirus and coronavirus infections. The company is headquartered in Bothell, Washington. more

Industry: PharmaceuticalsSector: Health Care

Returns

Time FrameCOCPSectorS&P500
1-Week Return1.32%-0.03%1.53%
1-Month Return-6.83%4.56%4.75%
3-Month Return-15.72%1.29%2.77%
6-Month Return9.06%-3.54%12.18%
1-Year Return16.61%1.59%22.34%
3-Year Return-70.58%13.55%38.91%
5-Year Return-70.85%40.85%80.7%
10-Year Return-99.22%105.52%190.95%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue6.56M2.01M5.43M--[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":30.68,"profit":true},{"date":"2021-12-31","value":82.68,"profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue4.00K238.90K239.50K241.60K15.17K[{"date":"2019-12-31","value":1.66,"profit":true},{"date":"2020-12-31","value":98.88,"profit":true},{"date":"2021-12-31","value":99.13,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":6.28,"profit":true}]
Gross Profit6.56M1.78M(239.50K)(241.60K)(15.17M)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":27.06,"profit":true},{"date":"2021-12-31","value":-3.65,"profit":false},{"date":"2022-12-31","value":-3.68,"profit":false},{"date":"2023-12-31","value":-231.23,"profit":false}]
Gross Margin99.94%88.14%(4.41%)(Infinity%)(Infinity%)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":88.19,"profit":true},{"date":"2021-12-31","value":-4.42,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}]
Operating Expenses8.87M11.60M14.22M18.14M22.55M[{"date":"2019-12-31","value":39.33,"profit":true},{"date":"2020-12-31","value":51.45,"profit":true},{"date":"2021-12-31","value":63.07,"profit":true},{"date":"2022-12-31","value":80.44,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(48.41M)(9.59M)(14.22M)(38.83M)(18.56M)[{"date":"2019-12-31","value":-4840600000,"profit":false},{"date":"2020-12-31","value":-958600000,"profit":false},{"date":"2021-12-31","value":-1422100000,"profit":false},{"date":"2022-12-31","value":-3882900000,"profit":false},{"date":"2023-12-31","value":-1855900000,"profit":false}]
Total Non-Operating Income/Expense218.00K(70.00K)32.00K(10.00K)1.03M[{"date":"2019-12-31","value":21.06,"profit":true},{"date":"2020-12-31","value":-6.76,"profit":false},{"date":"2021-12-31","value":3.09,"profit":true},{"date":"2022-12-31","value":-0.97,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income(48.17M)(9.65M)(14.19M)(38.84M)(17.98M)[{"date":"2019-12-31","value":-4816900000,"profit":false},{"date":"2020-12-31","value":-964800000,"profit":false},{"date":"2021-12-31","value":-1418500000,"profit":false},{"date":"2022-12-31","value":-3883700000,"profit":false},{"date":"2023-12-31","value":-1798400000,"profit":false}]
Income Taxes19.00K8.00K4.00K8.00K(1.00)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":42.11,"profit":true},{"date":"2021-12-31","value":21.05,"profit":true},{"date":"2022-12-31","value":42.11,"profit":true},{"date":"2023-12-31","value":-0.01,"profit":false}]
Income After Taxes(48.19M)(9.66M)(14.19M)(38.84M)(17.98M)[{"date":"2019-12-31","value":-4818800000,"profit":false},{"date":"2020-12-31","value":-965600000,"profit":false},{"date":"2021-12-31","value":-1418900000,"profit":false},{"date":"2022-12-31","value":-3884500000,"profit":false},{"date":"2023-12-31","value":-1798399900,"profit":false}]
Income From Continuous Operations(48.17M)(9.65M)(14.19M)(38.84M)(18.02M)[{"date":"2019-12-31","value":-4816900000,"profit":false},{"date":"2020-12-31","value":-964800000,"profit":false},{"date":"2021-12-31","value":-1418500000,"profit":false},{"date":"2022-12-31","value":-3883700000,"profit":false},{"date":"2023-12-31","value":-1802100000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(48.19M)(9.66M)(14.19M)(38.84M)(17.98M)[{"date":"2019-12-31","value":-4818800000,"profit":false},{"date":"2020-12-31","value":-965600000,"profit":false},{"date":"2021-12-31","value":-1418900000,"profit":false},{"date":"2022-12-31","value":-3884500000,"profit":false},{"date":"2023-12-31","value":-1798400000,"profit":false}]
EPS (Diluted)(0.72)(2.28)(1.92)(4.73)(1.90)[{"date":"2019-12-31","value":-72,"profit":false},{"date":"2020-12-31","value":-228,"profit":false},{"date":"2021-12-31","value":-192,"profit":false},{"date":"2022-12-31","value":-473,"profit":false},{"date":"2023-12-31","value":-190,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

COCP
Cash Ratio 6.68
Current Ratio 7.32

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

COCP
ROA (LTM) -51.98%
ROE (LTM) -86.20%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

COCP
Debt Ratio Lower is generally better. Negative is bad. 0.22
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.78

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

COCP
Trailing PE NM
Forward PE NM
P/S (TTM) 92.45
P/B 1.48
Price/FCF NM
EV/R 17.89
EV/Ebitda 0.66
PEG NM

FAQs

What is Cocrystal Pharma Inc share price today?

Cocrystal Pharma Inc (COCP) share price today is $1.8541

Can Indians buy Cocrystal Pharma Inc shares?

Yes, Indians can buy shares of Cocrystal Pharma Inc (COCP) on Vested. To buy Cocrystal Pharma Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in COCP stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Cocrystal Pharma Inc be purchased?

Yes, you can purchase fractional shares of Cocrystal Pharma Inc (COCP) via the Vested app. You can start investing in Cocrystal Pharma Inc (COCP) with a minimum investment of $1.

How to invest in Cocrystal Pharma Inc shares from India?

You can invest in shares of Cocrystal Pharma Inc (COCP) via Vested in three simple steps:

  • Click on Sign Up or Invest in COCP stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Cocrystal Pharma Inc shares
What is Cocrystal Pharma Inc 52-week high and low stock price?

The 52-week high price of Cocrystal Pharma Inc (COCP) is $3.26. The 52-week low price of Cocrystal Pharma Inc (COCP) is $1.32.

What is Cocrystal Pharma Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Cocrystal Pharma Inc (COCP) is 1.48

What is the Market Cap of Cocrystal Pharma Inc?

The market capitalization of Cocrystal Pharma Inc (COCP) is $18.86M

What is Cocrystal Pharma Inc’s stock symbol?

The stock symbol (or ticker) of Cocrystal Pharma Inc is COCP

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top